Harvard Bioscience (HBIO) May Have Begun Sale Process -DealReporter
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Shares of Harvard Bioscience (Nasdaq: HBIO) have just surged into positive territory on the heels of headlines from DealReporter which suggest the company recently started looking for possible buyers.
The stock is now up 9 percent to $4.90.
The stock is now up 9 percent to $4.90.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Evolution Petroleum closes $16M Midland Basin royalty acquisition
- Real and RE/MAX Holdings receive court approval for merger
Create E-mail Alert Related Categories
Mergers and Acquisitions, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
